BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$74.36
−1.39%Margins
Gross margin
93.1%
EBITDA margin
-87.1%
EBIT margin
-78.6%
Net margin
-100.6%
FCF margin
-85.6%
27.7%
Return on equity
-57.2%
Return on assets
2535.0%
Return on invested capital
0.53x
Asset turnover
-$586.6M
Cash from operations
$3.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026